Nasdaq · CIK 0001682852
MRNA Moderna, Inc.
Insider trading from SEC Form 4. Last filing Mar 4, 2025.
Last 90 days
Net insider value
$0
no open-market trades
Buys
0
$0 by 0 insiders
Sells
0
$0 by 0 insiders
Insiders on file
4
with a Form 4 at this company
Signals
Open-market buys and sells at Moderna, Inc., scored.
| Score | Side | Insider | Value | Shares | Holdings change | Price context | Filed |
|---|---|---|---|---|---|---|---|
| 50Moderate | buy | Bancel Stephane Chief Executive Officer | $5.0M | 160,314 | +2% | - | |
| 0Weak | sell 310b5-1 | Klinger Shannon Thyme Chief Legal Officer | $24k | 529 | -3% | - | |
| 0Weak | sell 310b5-1 | Hoge Stephen President | $14k | 314 | -0% | - | |
| 0Weak | sell 310b5-1 | Klinger Shannon Thyme Chief Legal Officer | $4,849 | 112 | -1% | - | |
| 0Weak | sell 310b5-1 | Hoge Stephen President | $12k | 291 | -0% | - | |
| 2Weak | sell 310b5-1 | Klinger Shannon Thyme Chief Legal Officer | $61k | 1,418 | -7% | - | |
| 14Weak | sell 310b5-1 | Mock James M Chief Financial Officer | $61k | 1,420 | -11% | - | |
| 0Weak | sell10b5-1 | Hoge Stephen President | $13k | 277 | -0% | - |
Congressional trades
6 trades in MRNA disclosed by members of Congress under the STOCK Act. All congressional trades.
| Member | Type | Asset | Amount | Traded | Filed |
|---|---|---|---|---|---|
| Maria Elvira Salazar House · R-FL | Partial sale | MRNA Moderna, Inc. - Common Stock | $1,001 to $15k | Sep 24, 2026 | 13 days after the trade |
| Maria Elvira Salazar House · R-FL | Partial sale | MRNA Moderna, Inc. - Common Stock | $1,001 to $15k | Aug 19, 2026 | 21 days after the trade |
| Maria Elvira Salazar House · R-FL | Purchase | MRNA Moderna, Inc. - Common Stock | $1,001 to $15k | Aug 19, 2026 | 21 days after the trade |
| Robert P. Bresnahan, Jr. House · R-PA | Sale | MRNA Moderna, Inc. - Common Stock | $1,001 to $15k | Apr 8, 2025 | 30 days after the trade |
| Robert P. Bresnahan, Jr. House · R-PA | Purchase | MRNA Moderna, Inc. - Common Stock | $1,001 to $15k | Feb 25, 2025 | 30 days after the trade |
| Julie Johnson House · D-TX | Sale | MRNA Moderna, Inc. - Common Stock | $1,001 to $15k | Jan 15, 2025 | 28 days after the trade |
Transactions
The last 34 rows filed, every code.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Mar 3, 2025 | Bancel Stephane Chief Executive Officer | POpen-market purchase Common Stockindirect: See Footnote | +102,821 | $31.04 | $3.2M | 9,153,193 | Mar 4, 2025 |
| Mar 3, 2025 | Bancel Stephane Chief Executive Officer | POpen-market purchase Common Stockindirect: See Footnote | +57,493 | $31.53 | $1.8M | 9,210,686 | Mar 4, 2025 |
| Mar 1, 2025 | Bancel Stephane Chief Executive Officer | AGrant or award Stock Option (Right to Buy)derivative | +357,065 | $0.00 | $0 | 357,065 | Mar 3, 2025 |
| Feb 12, 2025 | Bancel Stephane Chief Executive Officer | AGrant or award Common Stock | +13,233 | $0.00 | $0 | 5,500,297 | Feb 14, 2025 |
| Feb 12, 2025 | Bancel Stephane Chief Executive Officer | FTax withholding Common Stock | -6,400 | $30.93 | $198k | 5,493,897 | Feb 14, 2025 |
| Dec 6, 2024 | Klinger Shannon Thyme Chief Legal Officer | MOption exercise Common Stock10b5-1 | +1,138 | - | - | 20,975 | Dec 10, 2024 |
| Dec 9, 2024 | Klinger Shannon Thyme Chief Legal Officer | SOpen-market sale Common Stock10b5-1 | -529 | $44.68 | $24k | 20,446 | Dec 10, 2024 |
| Dec 6, 2024 | Klinger Shannon Thyme Chief Legal Officer | MOption exercise Restricted Stock Unitsderivative10b5-1 | -1,138 | $0.00 | $0 | 2,278 | Dec 10, 2024 |
| Dec 5, 2024 | Klinger Shannon Thyme Chief Legal Officer | AGrant or award Restricted Stock Unitsderivative | +188,761 | $0.00 | $0 | 188,761 | Dec 6, 2024 |
| Dec 5, 2024 | Mock James M Chief Financial Officer | AGrant or award Restricted Stock Unitsderivative | +188,761 | $0.00 | $0 | 188,761 | Dec 6, 2024 |
| Dec 2, 2024 | Hoge Stephen President | MOption exercise Common Stock10b5-1 | +651 | - | - | 1,444,218 | Dec 4, 2024 |
| Dec 2, 2024 | Klinger Shannon Thyme Chief Legal Officer | MOption exercise Common Stock10b5-1 | +232 | - | - | 19,949 | Dec 4, 2024 |
| Dec 3, 2024 | Klinger Shannon Thyme Chief Legal Officer | SOpen-market sale Common Stock10b5-1 | -112 | $43.30 | $4,849 | 19,837 | Dec 4, 2024 |
| Dec 3, 2024 | Hoge Stephen President | SOpen-market sale Common Stock10b5-1 | -314 | $43.30 | $14k | 1,443,904 | Dec 4, 2024 |
| Dec 2, 2024 | Klinger Shannon Thyme Chief Legal Officer | MOption exercise Restricted Stock Unitsderivative10b5-1 | -232 | $0.00 | $0 | 1,164 | Dec 4, 2024 |
| Dec 2, 2024 | Hoge Stephen President | MOption exercise Restricted Stock Unitsderivative10b5-1 | -651 | $0.00 | $0 | 3,259 | Dec 4, 2024 |
| Nov 27, 2024 | Hoge Stephen President | MOption exercise Common Stock10b5-1 | +610 | - | - | 1,443,858 | Dec 2, 2024 |
| Nov 27, 2024 | Klinger Shannon Thyme Chief Legal Officer | MOption exercise Common Stock10b5-1 | +329 | - | - | 18,483 | Dec 2, 2024 |
| Nov 27, 2024 | Mock James M Chief Financial Officer | MOption exercise Common Stock10b5-1 | +1,326 | - | - | 10,831 | Dec 2, 2024 |
| Nov 29, 2024 | Hoge Stephen President | SOpen-market sale Common Stock10b5-1 | -291 | $42.79 | $12k | 1,443,567 | Dec 2, 2024 |
| Nov 27, 2024 | Mock James M Chief Financial Officer | MOption exercise Common Stock10b5-1 | +329 | - | - | 11,160 | Dec 2, 2024 |
| Nov 27, 2024 | Klinger Shannon Thyme Chief Legal Officer | MOption exercise Common Stock10b5-1 | +2,652 | - | - | 21,135 | Dec 2, 2024 |
| Nov 29, 2024 | Klinger Shannon Thyme Chief Legal Officer | SOpen-market sale Common Stock10b5-1 | -1,418 | $42.79 | $61k | 19,717 | Dec 2, 2024 |
| Nov 27, 2024 | Mock James M Chief Financial Officer | MOption exercise Common Stock10b5-1 | +1,326 | - | - | 12,486 | Dec 2, 2024 |
| Nov 27, 2024 | Klinger Shannon Thyme Chief Legal Officer | MOption exercise Restricted Stock Unitsderivative10b5-1 | -329 | $0.00 | $0 | 2,959 | Dec 2, 2024 |
| Nov 29, 2024 | Mock James M Chief Financial Officer | SOpen-market sale Common Stock10b5-1 | -1,420 | $42.79 | $61k | 11,066 | Dec 2, 2024 |
| Nov 27, 2024 | Klinger Shannon Thyme Chief Legal Officer | MOption exercise Restricted Stock Unitsderivative10b5-1 | -2,652 | $0.00 | $0 | 2,653 | Dec 2, 2024 |
| Nov 27, 2024 | Hoge Stephen President | MOption exercise Restricted Stock Unitsderivative10b5-1 | -610 | $0.00 | $0 | 5,495 | Dec 2, 2024 |
| Nov 27, 2024 | Mock James M Chief Financial Officer | MOption exercise Performance Stock Unitsderivative10b5-1 | -1,326 | $0.00 | $0 | 1,326 | Dec 2, 2024 |
| Nov 27, 2024 | Mock James M Chief Financial Officer | MOption exercise Restricted Stock Unitsderivative10b5-1 | -329 | $0.00 | $0 | 2,959 | Dec 2, 2024 |
| Nov 27, 2024 | Mock James M Chief Financial Officer | MOption exercise Restricted Stock Unitsderivative10b5-1 | -1,326 | $0.00 | $0 | 1,326 | Dec 2, 2024 |
| Nov 8, 2024 | Hoge Stephen President | MOption exercise Common Stock10b5-1 | +523 | - | - | 1,443,525 | Nov 12, 2024 |
| Nov 11, 2024 | Hoge Stephen President | SOpen-market sale Common Stock10b5-1 | -277 | $46.10 | $13k | 1,443,248 | Nov 12, 2024 |
| Nov 8, 2024 | Hoge Stephen President | MOption exercise Restricted Stock Unitsderivative10b5-1 | -523 | $0.00 | $0 | 523 | Nov 12, 2024 |
Insiders
Everyone who has filed a Form 4 here.
- Bancel StephaneChief Executive Officer
- Hoge StephenPresident
- Klinger Shannon ThymeChief Legal Officer
- Mock James MChief Financial Officer
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.